2 results
Approved WMOCompleted
Compare Progression Free Survival (PFS) for brivanib versus placebo in subjects with advanced solid tumors with FGF-2 over-expression and who have obtained stable disease after 12 weeks of treatment with brivanib separately for each tumor.
Approved WMOCompleted
The primary objective of the study is to demonstrate the effectiveness of the computer algorithm (LOGIC-Insulin) against the standard routine protocol for the normalisation of blood glucose concentrations in the ICU.The secondary objective of the…